FI951986A7 - Aallonpituusspesifiset valoherkät porfasyaniini- ja laajennetut porfyriinin kaltaiset yhdisteet ja niiden valmistusmenetelmät ja käyttö - Google Patents

Aallonpituusspesifiset valoherkät porfasyaniini- ja laajennetut porfyriinin kaltaiset yhdisteet ja niiden valmistusmenetelmät ja käyttö Download PDF

Info

Publication number
FI951986A7
FI951986A7 FI951986A FI951986A FI951986A7 FI 951986 A7 FI951986 A7 FI 951986A7 FI 951986 A FI951986 A FI 951986A FI 951986 A FI951986 A FI 951986A FI 951986 A7 FI951986 A7 FI 951986A7
Authority
FI
Finland
Prior art keywords
porphacyanine
wavelength
compounds
preparation
methods
Prior art date
Application number
FI951986A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI951986A0 (fi
Inventor
Hang Tang
Lily Xie
Tilak Wijesekera
David Dolphin
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Publication of FI951986A0 publication Critical patent/FI951986A0/fi
Publication of FI951986A7 publication Critical patent/FI951986A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0485—Porphyrins, texaphyrins wherein the nitrogen atoms forming the central ring system complex the radioactive metal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI951986A 1992-10-30 1995-04-26 Aallonpituusspesifiset valoherkät porfasyaniini- ja laajennetut porfyriinin kaltaiset yhdisteet ja niiden valmistusmenetelmät ja käyttö FI951986A7 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/968,966 US5405957A (en) 1992-10-30 1992-10-30 Wavelength-specific photosensitive compounds and expanded porphyrin-like compounds and methods of use
US08/077,789 US5512675A (en) 1992-10-30 1993-06-15 Methods for preparing porphyrin-like compounds
PCT/CA1993/000470 WO1994010172A1 (en) 1992-10-30 1993-10-29 Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof

Publications (2)

Publication Number Publication Date
FI951986A0 FI951986A0 (fi) 1995-04-26
FI951986A7 true FI951986A7 (fi) 1995-06-21

Family

ID=25515006

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951986A FI951986A7 (fi) 1992-10-30 1995-04-26 Aallonpituusspesifiset valoherkät porfasyaniini- ja laajennetut porfyriinin kaltaiset yhdisteet ja niiden valmistusmenetelmät ja käyttö

Country Status (12)

Country Link
US (2) US5405957A (OSRAM)
EP (1) EP0666859A1 (OSRAM)
JP (1) JP3108438B2 (OSRAM)
KR (1) KR100284928B1 (OSRAM)
CN (1) CN1092424A (OSRAM)
AU (1) AU683856B2 (OSRAM)
CA (1) CA2147509A1 (OSRAM)
FI (1) FI951986A7 (OSRAM)
NO (1) NO951635L (OSRAM)
TW (1) TW268953B (OSRAM)
WO (1) WO1994010172A1 (OSRAM)
ZA (1) ZA938108B (OSRAM)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817830A (en) * 1992-08-14 1998-10-06 Trustees Of The University Of Pennsylvania Pyrrolic compounds
US5599924A (en) * 1992-08-14 1997-02-04 Trustees Of The University Of Pennsylvania Electron-deficient porphyrins and processes and intermediates for preparing same
US5726304A (en) * 1992-10-30 1998-03-10 The University Of British Columbia Porphocyanine and CNC-expanded porphyrins
US6214876B1 (en) * 1994-07-21 2001-04-10 Eli Lilly And Company Indene-1-acetamide sPLA2 inhibitors
CA2206203A1 (en) * 1997-05-27 1998-11-27 University Of British Columbia Photoactivation of endogenous porphyrins for treatment of psoriasis
US6277337B1 (en) * 1998-07-21 2001-08-21 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
ATE335513T1 (de) * 1998-10-16 2006-09-15 Gen Hospital Corp Photosensitizer-konjugate zur zielrichtung von intrazellulare pathogene
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
US6376483B1 (en) 1999-05-27 2002-04-23 Miravant Pharmaceuticals, Inc. Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production
US7073510B2 (en) * 2000-02-11 2006-07-11 The General Hospital Corporation Photochemical tissue bonding
US8215314B2 (en) * 2000-02-11 2012-07-10 The General Hospital Corporation Photochemical tissue bonding
JP5101778B2 (ja) * 2000-02-11 2012-12-19 ザ ジェネラル ホスピタル コーポレイション 光化学作用による組織接着
US7282215B2 (en) 2000-05-08 2007-10-16 The University Of British Columbia Supports for photosensitizer formulations
CA2408323C (en) * 2000-05-08 2012-06-12 The University Of British Columbia Drug delivery systems for photodynamic therapy
AU2002232912A1 (en) * 2000-11-10 2002-05-21 The University Of Akron Carbene porphyrins and carbene porphyrinoids for use in medical diagnosis and treatment
WO2002096366A2 (en) * 2001-05-31 2002-12-05 Miravant Pharmaceuticals, Inc. Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
EP1605847B1 (en) * 2003-03-07 2009-09-16 Board Of Regents, The University Of Texas System Antibody-targeted photodynamic therapy
CN1926141A (zh) * 2003-09-05 2007-03-07 阿克伦大学 用作放射性药物和抗生素的n－杂环卡宾的金属配合物
US8519146B2 (en) * 2004-09-07 2013-08-27 The University Of Akron Metal complexes of N-heterocyclic carbenes as antibiotics
AU2005280639A1 (en) * 2004-02-17 2006-03-09 Billy T. Fowler Methods, compositions, and apparatuses for forming macrocyclic compounds
US20060171845A1 (en) * 2005-01-31 2006-08-03 Dakota Technologies, Inc. Sensors for measuring analytes
EP2129788B1 (en) 2007-01-30 2014-09-03 SETA BioMedicals, LLC Luminescent compounds
US8782681B2 (en) 2007-03-08 2014-07-15 The Nielsen Company (Us), Llc Method and system for rating media and events in media based on physiological data
HRP20070111B1 (hr) * 2007-03-16 2014-11-21 Institut Ruđer Bošković Derivati adamantanskih dipirometana, metoda priprave i upotreba za detekciju aniona
WO2008150830A2 (en) * 2007-05-31 2008-12-11 The University Of Akron Metal complexes incorporated within biodegradable nanoparticles and their use
WO2009015112A2 (en) * 2007-07-23 2009-01-29 The University Of Akron Metal complexes incorporated within biodegradable nanoparticles and their use
US20110092961A1 (en) * 2008-08-13 2011-04-21 Searete Llc Artificial cells
MX337922B (es) 2008-12-16 2016-03-28 Valeant Pharmaceuticals Int Combinacion de terapia fotodinamica y agentes anti-vegf en el tratamiento de neovasculatura coroidal indeseable.
US8829020B2 (en) 2009-07-16 2014-09-09 Mallinckrodt Llc Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
PL2531206T3 (pl) 2010-02-04 2017-12-29 Morphotek, Inc. Polipeptydy i koniugaty chlorotoksyny i ich zastosowanie
WO2013003507A1 (en) 2011-06-27 2013-01-03 Morphotek, Inc. Multifunctional agents
CN104040341B (zh) 2011-10-25 2016-12-28 斯隆－凯特林纪念癌症中心 用于前列腺癌的诊断、预测和治疗的游离psa抗体
CN102680702B (zh) * 2012-04-28 2014-12-17 广州鸿琪光学仪器科技有限公司 一种快速定量检测c-反应蛋白的免疫荧光试纸条组件、及其制成的检测卡组件和制备方法
CN102680703B (zh) * 2012-04-28 2014-12-17 广州鸿琪光学仪器科技有限公司 一种快速定量检测肌红蛋白的免疫荧光试纸条组件及其制成的检测卡组件和制备方法
CN102680704B (zh) * 2012-04-28 2015-02-11 广州鸿琪光学仪器科技有限公司 一种快速定量检测微量白蛋白的免疫荧光试纸条组件及其制成的检测卡组件和制备方法
US9365542B2 (en) 2012-10-26 2016-06-14 Memorial Sloan-Kettering Cancer Center Modulators of resistant androgen receptor
CA3142856A1 (en) 2013-12-23 2015-07-02 Memorial Sloan-Kettering Cancer Center Methods and compositions for treating cancer using peptide nucleic acid-based agents
CN109575036B (zh) * 2018-12-11 2020-09-22 怀化学院 金属血卟啉双醚二酯类化合物，催化剂及其制备方法以及环己烷催化氧化方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051415A (en) * 1986-01-02 1991-09-24 The University Of Toledo Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions
DE3635820A1 (de) * 1986-10-22 1988-04-28 Basf Ag Vinyloge porphyrine
US4935498A (en) * 1989-03-06 1990-06-19 Board Of Regents, The University Of Texas System Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
US5162509A (en) * 1989-03-06 1992-11-10 Board Of Regents, The University Of Texas System Process for preparing expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
US5124449A (en) * 1990-09-20 1992-06-23 Basf Aktiengesellschaft Azaporphyrin derivatives

Also Published As

Publication number Publication date
KR950704321A (ko) 1995-11-17
EP0666859A1 (en) 1995-08-16
CN1092424A (zh) 1994-09-21
FI951986A0 (fi) 1995-04-26
US5512675A (en) 1996-04-30
NO951635D0 (no) 1995-04-28
NO951635L (no) 1995-06-09
AU683856B2 (en) 1997-11-27
KR100284928B1 (ko) 2001-03-15
ZA938108B (en) 1995-05-02
TW268953B (OSRAM) 1996-01-21
CA2147509A1 (en) 1994-05-11
AU5414394A (en) 1994-05-24
JPH08502497A (ja) 1996-03-19
JP3108438B2 (ja) 2000-11-13
WO1994010172A1 (en) 1994-05-11
US5405957A (en) 1995-04-11

Similar Documents

Publication Publication Date Title
FI951986A7 (fi) Aallonpituusspesifiset valoherkät porfasyaniini- ja laajennetut porfyriinin kaltaiset yhdisteet ja niiden valmistusmenetelmät ja käyttö
FI941137A7 (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
FI953666A7 (fi) Hetersykliset yhdisteet ja niiden valmistus ja käyttö
FI954131L (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
FI945912L (fi) Proteinoidikantajat ja menetelmät niiden valmistamiseksi sekä niiden käyttö
FI953981A7 (fi) 2-Bentsyyli-polysykliset guaniinijohdannaiset ja menetelmä niiden valmistamiseksi
FI954130L (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
FI20000516A7 (fi) Bis-indolyylimaleimidijohdannaiset ja niiden valmistus
FI955051A7 (fi) Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö
FI930747A7 (fi) Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö
FI935074A7 (fi) Uusia tiopyranopyrrolijohdannaisia ja niiden valmistus
FI945625A7 (fi) Indolokarbatsoli-imidit ja niiden käyttö
FI935887A7 (fi) Tiatzolidiinidionijohdannaiset, niiden valmistus ja käyttö
FI943313L (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
FI930746A7 (fi) Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö
FI932794A7 (fi) Orgaaniset cerium (IV) yhdisteet ja niiden valmistus ja käyttö
FI942963A7 (fi) Imidatsokinatsoliiniyhdisteitä ja niiden valmistus ja käyttö
FI932992A7 (fi) Fungisiidisia fenyylibentsamideja ja menetelmät niiden valmistamiseksi
FI940775L (fi) alfa-fenyyli-isoseriinijohdannaisten valmistusmentelmä ja niiden käyttö
FI953021L (fi) 4-bentsoyyli-isoksatsolin johdannaisia ja niiden käyttö herbisideinä
FI923475A7 (fi) Substituoidut ureayhdisteet ja niiden valmistus ja käyttö
FI981359L (fi) Uudet tiomarinolin johdannaiset ja menetelmät niiden valmistamiseksi
FI933642A7 (fi) Koostumus ja menetelmiä luun muodostamiseksi
FI932863A7 (fi) Menetelmä uusien tienotiatsiinijohdosten valmistamiseksi ja niiden käyttö
FI944728L (fi) Uudet perhydroisoindolijohdannaiset ja niiden valmistus

Legal Events

Date Code Title Description
FD Application lapsed